Mostrar 1 - 1 resultats de 1 per cerca 'on behalf of the OPTION-DM group', hora de la petició: 0.02sec
Refinar resultats
-
1
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlle... per Dinesh Selvarajah, Jennifer Petrie, David White, Steven Julious, Oscar Bortolami, Cindy Cooper, Mike Bradburn, Amanda Loban, Helen Bowler, Lizzie Swaby, Katie Sutherland, Solomon Tesfaye, on behalf of the OPTION-DM group
Publicat 2018-10-01
Article